“Efzofitimod: a novel anti-inflammatory agent for sarcoidosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 40, no. 1, p. e2023011, Mar. 2023, doi: 10.36141/svdld.v40i1.14396.